quinazolines has been researched along with dc 015 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, TF; Lee, YM; Sheu, JR; Yen, MH | 1 |
| Chern, JW; Lee, YM; Peng, IH; Sheu, JR; Yen, MH | 1 |
| Lee, YM; Peng, IH; Sheu, JR; Yen, MH | 1 |
| Chern, JW; Hong, CY; Huang, YT; Lin, HC; Wu, HL | 1 |
| Chern, JW; Hong, CY; Huang, YT; Lin, HC; Lin, LC | 1 |
5 other study(ies) available for quinazolines and dc 015
| Article | Year |
|---|---|
Effect of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist, comparison with prazosin on noradrenaline-induced platelet aggregation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Platelet Aggregation; Platelet Aggregation Inhibitors; Prazosin; Quinazolines; Rats | 1995 |
Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Binding, Competitive; Blood Pressure; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypertension; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Phosphatidylinositols; Prazosin; Quinazolines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Serotonin Antagonists; Vasoconstriction | 1996 |
Effects of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoproteins; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Prazosin; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension.
Topics: Adrenergic alpha-Antagonists; Animals; Drug Administration Schedule; Drug Therapy, Combination; Hemodynamics; Hemostatics; Hypertension, Portal; Male; Octreotide; Quinazolines; Rats; Rats, Sprague-Dawley | 1998 |
Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha 1 adrenoceptor antagonist administration on anesthetized portal hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Portal; Lypressin; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Terlipressin; Venous Pressure | 1999 |